Five people died near receiving the third vaccine dose against Corona, but it is estimated that this is a proximity of times and not a direct link to the vaccine.
The deceased are between the ages of 65 and 85, with one of them dying from a sepsis infection and the other four having significant background illnesses.
A report released today (Thursday) by the Ministry of Health on the subject stated that "in examining the cases, it is not possible to determine a causal link between receiving the vaccine and dying."
The third dose of the vaccine has so far reported 11 serious cases following the vaccine: two cases of herpes zoster, one case of respiratory disorder, one case of blurred vision, one case of severe allergic reaction (anaphylaxis) and one event of fever and confusion.
The data sum up 1.132 million third vaccine doses given.
As mentioned, so far the rate of side effects in the third dose is lower than that recorded in the first and second dose.
For example, the prevalence of those who reported fatigue was 256 per million doses in the first dose, 273 in the second dose and 21 in the third dose.
PM Bennett: "Estimates that a third vaccine from the age of 40 will be approved tomorrow" // Photo: GPO
Among the mild side effects in the third immunity were 159 cases of general weakness, fever, headache, fatigue, nausea, loss of appetite, muscle aches, cough and rapid pulse.
69 cases of local symptoms in the injection site were also found: pain, swelling, redness, local rash, enlarged lymph nodes and movement disorder.
In addition, three cases of past virological symptoms (loss of consciousness, blurred vision, loss of taste and smell, and seven cases of allergic symptoms were also reported.
The Ministry of Health also reported that 6 cases of myocarditis (inflammation of the heart muscle) have been reported so far following the administration of corona vaccines between the ages of 12 and 15. Out of 238,000 vaccines in the first dose, one case was reported, and out of 172,000 vaccines in the second dose About 5 cases.All the boys were released for further treatment at home.At the same time, another case of a 16 to 19 year old boy with myocarditis, a young man aged 42-20 and a thirty year old woman was reported.
The incidence of myocarditis is 1 in 18,282 in boys aged 12-15, and zero in girls after a second dose.
After the first dose, the rate is 1 in 121,000 boys and zero in girls.
Among 16- to 19-year-olds, the rate is 6,347 boys and one in 104,000 girls after a second dose.
